Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more

Location: 701 Anacapa Street, Santa Barbara, CA, 93101, United States | Website: https://phytanix.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

4.029M

52 Wk Range

$1.83 - $14.28

Previous Close

$2.10

Open

$2.09

Volume

23,811

Day Range

$2.01 - $2.10

Enterprise Value

3.85M

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

11.21%

Institutional Own.

10.11%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
PT00114 Details
Major depression, anxiety disorders, PTSD, addiction / substance use disorders

Phase 1/2

Data readout